BOSTON–(BUSINESS WIRE)–PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”) plans to announce its half-yearly results for the six months ended June 30, 2022, on Thursday, August 25, 2022. A presentation and conference call for analysts and shareholders will take place at 9:00am EDT / 2:00pm BST on the day of publication, and … [Read more…]
Labs can now launch next-gen testing in days versus months and improve patient experience and outcomes SAN FRANCISCO–(BUSINESS WIRE)–1health.io Inc. (“1health”), an industry-leading healthcare tech company that empowers laboratories to make diagnostic testing accessible and affordable at scale, announces the launch of its Next Generation Diagnostic Platform. With 1health’s innovative platform, laboratories can expand market … [Read more…]
AHF Zoom Press Telecon: Thurs., August 4 @ 11:00 am PT Now that both the State of California and Los Angeles County have declared states of emergency on monkeypox, AHF is urging L.A. County health officials to swiftly ramp up and improve its uneven response to the virus outbreak that is primarily affecting gay men … [Read more…]
DIC leverages world-class algae cultivation tech, expanding health, personal care offerings TOKYO–(BUSINESS WIRE)–#Biotech—DIC Corporation (TOKYO:4631) and biotech startup Green Science Materials, Inc. (GSM) expand their collaboration on Suizenji Nori blue-green algae and SACRANTM polysaccharide extract, developing Suizenji Nori indoor mass cultivation technology needed to deliver the stable production of SACRANTM required for global scale. This … [Read more…]
Financial Highlights Second Quarter 2022: Revenue of $246.2 million, an increase of 16% from second quarter 2021 GAAP net loss of $490.0 million, which includes a $519.9 million loss on impairment related to our decision to exit the Episodes of Care Services segment. Non-GAAP adjusted EBITDA1 of $62.6 million, an increase of 15% from second … [Read more…]
FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN), a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignancies, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, plans to participate in a fireside chat at the 2022 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 10, 2022 … [Read more…]
Q2 2022 reported revenue growth of 3.1% year-over-year (yoy); organic revenue growth of 8.8% Q2 2022 GAAP EPS $0.33; non-GAAP EPS $0.45, up 2.3% yoy Maintaining FY 2022 guidance for high, single-digit organic revenue growth, non-GAAP operating profit margin expansion and non-GAAP EPS increase BILLERICA, Mass.–(BUSINESS WIRE)–$BRKR #BRKR—Bruker Corporation (Nasdaq: BRKR) today announced financial results … [Read more…]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal Touchon, President and Chief Executive Officer, will present at the Canaccord Genuity 42nd Annual Growth Conference on … [Read more…]
– Monjuvi® U.S. net product sales of US$ 23.3 million (€ 21.7 million) for the second quarter 2022, a 25% Q-Q growth and 29% Y-Y growth – Efficacy and safety data of pelabresib for potential treatment improvement in myelofibrosis presented at EHA Congress 2022 – Entered into collaboration with Pfizer and Incyte for a combination … [Read more…]
MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the second quarter ended June 30, 2022. Second Quarter and Recent Highlights Reported quarterly revenue of $18.2 million in the second quarter of 2022 compared with $21.7 million in the second quarter of 2021 Revenue … [Read more…]
